Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations

Abstract

Our study shows the clinical relevance of i.v. VPA as first-line therapy of SE in patients with medical conditions contraindicating the use of traditional first-line antiepileptic drugs for SE, and in those presenting with specific forms of SE.